Ganitumab and metformin plus standard neoadjuvant therapy in stage 2/3 breast cancer
Douglas Yee(University of Minnesota Medical Center), Jane Perlmutter(Gemini Computers (United States)), Angela DeMichele(University of Pennsylvania), Denise M. Wolf, Andres Forero‐Torres(Kirklin Clinic), Barbara Haley(Shaanxi Research Association for Women and Family), Erin D. Ellis(University of Hawaii Cancer Center), Adam L. Asare(Quantum Leap Healthcare Collaborative), Lajos Pusztai(Yale University), Scott Berry(Queen's University), Paula R. Pohlmann(The University of Texas MD Anderson Cancer Center), Lamorna Brown Swigart(University of California, San Francisco), Emanuel F. Petricoin(Center for Biologics Evaluation and Research), Amy Wilson(Quantum Leap Healthcare Collaborative), Qamar J. Khan(University of Kansas Medical Center), Julia Wulfkuhle(University of California, San Francisco), Rachel L. Yung(Seattle Cancer Care Alliance), Teresa Helsten(University of California, San Diego), Ruby Singhrao(University of California, San Francisco), Judy C. Boughey(Mayo Clinic in Arizona), Nola M. Hylton(University of California, San Francisco), Julia L. Clennell(Berry & Associates (United States)), Rita A. Mukhtar(University of California, San Francisco), Erica Stringer-Reasor(University of Alabama at Birmingham), Stacy L. Moulder(The University of Texas MD Anderson Cancer Center), Smita Asare(Quantum Leap Healthcare Collaborative), Kristen K. Edmiston(Nova Medical (United States)), Meredith Buxton(Center for Effective Global Action), A. Jo Chien(University of California, San Francisco), Melanie Majure(University of California, San Francisco), Hyo S. Han(Moffitt Cancer Center), Kathy S. Albain(Loyola University Chicago), Christina Yau(Hospital Authority), Amy S. Clark(Abramson Center for Jewish Life), Jeffrey B. Matthews(University of California, San Francisco), Kathleen Kemmer(University of Michigan), Claudine Isaacs(Georgetown University), Gillian L. Hirst(University of California, San Francisco), Carla I. Falkson, Paul Haluska(Mayo Clinic in Arizona), Anne M. Wallace(University of California San Diego), Karthik V. Giridhar(WinnMed), Anthony Elias(University of Colorado Cancer Center), Heather Beckwith(University of Minnesota Medical Center), Melissa Paoloni(National Institutes of Health), Ashish Sanil(Berry & Associates (United States)), Patricia A. Robinson(Loyola University Chicago), Michelle Melisko(University of California, San Francisco), Debu Tripathy(The University of Texas MD Anderson Cancer Center), Rita Nanda(University of Chicago)
Cited by 29
Related Papers
The Immune Landscape of Cancer
|Immunity|2018|6.2k
Pembrolizumab for Early Triple-Negative Breast Cancer
|New England Journal of Medicine|2020|3.1k
Measurement of Residual Breast Cancer Burden to Predict Survival After Neoadjuvant Chemotherapy
|Journal of Clinical Oncology|2007|1.6k